As estimated by IQ4I Research, the incontinence and ostomy care global market is expected to reach $24,577.9 million by 2026 growing at a mid single digit from 2019 to 2026 due to increase in population prone to aging related medical conditions, growing prevalence of medical conditions such as women health related conditions (e.g. childbirth, menopause), inflammatory bowel diseases (crohn’s disease and ulcerative colitis), neurological diseases (multiple sclerosis, Parkinson’s disease), oncology (colorectal and prostate cancer) and others diseases, increasing awareness & acceptance of the condition of incontinence & ostomy, growing economies and increasing demand for better healthcare facilities in emerging markets. The incontinence and ostomy market is segmented by product, utility, application, end-user and geography.
Based on the product type, the incontinence and ostomy care global market is segmented into incontinence and ostomy care. Incontinence care segment is the largest and fastest growing product segment is expected to grow at a mid single digit CAGR from 2019 to 2026. Based on disease type, the incontinence care market is classified into urinary incontinence and fecal incontinence, urinary incontinence is accounted for largest and fastest growing segment is expected to grow at a mid single digit CAGR from 2019 to 2026. Based on the product type, incontinence care market is segment into disposables and implantable device. Among these segments, disposables segment accounted for the largest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Implant devices is fastest growing segment at a high single digit CAGR from 2019 to 2026. In the disposable global market by type, the adult diapers segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit from 2019 to 2026. Incontinence Catheter is fastest growing segment at a mid single digit CAGR from 2019 to 2026. Among the overall adult diaper market by type, underwear & briefs segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Pads & Guards is fastest growing segment at a mid single digit CAGR from 2019 to 2026. Implant devices by product type, Sacral Nerve Stimulation (SNS) segment holds the highest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. Slings is fastest growing segment at a CAGR of high single digit from 2019 to 2026.
Ostomy care is growing at low single digit from 2019 to 2026. The ostomy care global market by surgery type, colostomy segment is the largest and fastest growing product segment expected to grow at low single digit CAGR from 2019 to 2026 due to increase prevalence of targeted diseases such as cancer and GI tract diseases. Based on product type the ostomy care global market is classified into ostomy bags, skin barriers, deodorants, irrigation products and others accessories like ostomy tape, removers, belts, detergents, stoma implants and stoma caps. The ostomy bags segment is the largest and fastest growing product segment and expected to grow at low single digit CAGR from 2019 to 2026. Among the ostomy bags, two-piece ostomy bags is the largest and fastest growing segment and expected to grow at mid single digit CAGR from 2019 to 2026 due to technological innovations in their designs.
Based on the utility, the incontinence and ostomy care global market is segmented into security & leakage control, protection & cleansing, odor control and irrigation products. Security & Leakage control segment is the largest and fastest growing segment and expected to grow at mid single digit CAGR from 2019 to 2026 due to increasing use of security and leakage control device for incontinence and stoma management and increasing technological advancement in these devices to increase efficiency.
Based on application, the incontinence and ostomy global market is segmented into women health related, neurological conditions, oncology, urinogenital diseases, GI Tract diseases and others. Women health related segment accounted for the largest revenue in 2019 and is expected to grow at mid single digit CAGR from 2019 to 2026 due to women are more prone to incontinence related problems such as damage to nerve controlling urine or fecal urge during childbirth and impaired sphincter function which is a result of pelvic floor weakness which in turn may be due to pregnancy & vaginal birth, surgeries related to uterus, aging and weakness of the connective tissue. Oncology segment is the fastest growing segment and is projected to grow at mid single digit CAGR from 2019 to 2026 due to increase in the prevalence of prostate, colorectal and bladder cancers.
Based on end-users of incontinence and ostomy care market has been segmented into hospitals, home care, and others that consist of clinics and research institutes. Homecare accounted for the largest revenue in 2019 and it expected to grow at mid single digit CAGR from 2019 to 2026 due to the availability of better and technologically advanced personalized incontinence and stoma management products. The hospitals is fastest growing segment and is projected to grow at a mid single digit CAGR from 2019 to 2026 due to increasing availability various advanced minimally invasive treatments.
Based on the region, the incontinence and ostomy care global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and Middle East & Africa). Europe accounted for the largest revenue in 2019 and is expected to growing at a low single digit CAGR from 2019 to 2026 due to increasing prevalence of targeted disease in the region, escalating geriatric population, increasing penetration and adoption of advanced products and increasing R&D spending for developing innovative and technologically advanced products.
The Asia-Pacific is the fastest growing region in incontinence and ostomy care market and is expected to grow at a high single digit CAGR from 2019 to 2026 due to elevating increasing geriatric population, increasing demand for better healthcare facilities, increasing penetration of reimbursement schemes in developing countries, elevating demand for better healthcare facilities from the population in the region and growing economies of the region, availability of various kinds of incontinence and ostomy management products and increasing medical tourism prospects of the region.
Some of the major players in incontinence and ostomy care market include Essity AB (Sweden), Coloplast A/S (Denmark), Kimberly-Clark Corporation (U.S.), Unicharm Corporation (Japan), ConvaTec Group Plc (U.K.), B. Braun Melsungen AG (Germany), Medtronic Plc (Ireland), Ontex (Belgium), Paul Hartmann AG (Germany), Procter & Gamble Company (U.S.), Hollister Incorporated (U.S.), Salts Healthcare (U.K.), First Quality Enterprises, Inc. (U.S.), Abena A/S (Denmark), Becton, Dickinson and Company (U.S.), Medline Industries, Inc., (U.S.), Domtar Corporation (U.S.) and others.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
2.6.7.1 AVERAGE SELLING PRICE ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in aging population
3.3.1.2 Development of innovative and personalized products
3.3.1.3 Increase in awareness and acceptance
3.3.1.4 Increase in prevalence of chronic diseases
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Environment and disposal concerns
3.3.2.2 Low cost manufactures
3.3.2.3 Alternative medical treatment
3.3.2.4 Limited reimbursement
3.4 REGULATORY AFFAIRS
3.4.1.1 ISO 9001: 2015 quality management system
3.4.1.2 ISO 13485 medical devices
3.4.1.3 ISO 10993 biological evaluation of medical devices
3.4.1.4 ISO 14971 risk management of medical devices
3.4.1.5 IEC 60601-1 medical electrical equipment standard
3.4.1.6 IEC 60601-1-11 home care safety
3.4.2 U.S.
3.4.3 EUROPE
3.4.4 JAPAN
3.4.5 CHINA
3.4.6 INDIA
3.5 PATENT ANALYSIS
3.6 TECHNOLOGICAL ADVANCEMENTS
3.6.1 SMART DIAPERS
3.6.2 SMART BAGS
3.6.3 WEARBLE DIAPER FREE DEVICES (DFREE)
3.6.4 WEARBLE PELVIC FLOOR MUSCLE STIMULATION DEVICES
3.6.5 ADVANCEMENTS IN BIOMATERIALS
3.6.6 INCREASED ABSORBENCE AND ANTIBACTERIAL SOLUTIONS
3.6.7 MOLDABLE TECHNOLOGY
3.6.8 NEXT GENERATION OSTOMY IMPLANTS
3.7 PORTER’S FIVE FORCE ANALYSIS
3.7.1 THREAT OF NEW ENTRANTS
3.7.2 THREAT OF SUBSTITUTES
3.7.3 BARGAINING POWER OF SUPPLIERS
3.7.4 BARGAINING POWER OF BUYERS
3.7.5 COMPETITIVE RIVALRY
3.8 SUPPLY CHAIN ANALYSIS
3.9 REIMBURSEMENT SCENARIO
3.10 PIPELINE ANALYSIS
3.11 INCONTINENCE AND OSTOMY CARE MARKET PENETRATION, PREVALENCE AND OPPORTUNITY
3.11.1 ADULT DIAPERS MARKET PENETRATION, PREVALENCE AND OPPORTUNITY
3.11.2 OSTOMY MARKET PENETRATION, PREVALENCE AND OPPORTUNITY
3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.12.1 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET SHARE ANALYSIS
3.12.2 INCONTINENCE CARE GLOBAL MARKET SHARE ANALYSIS
3.12.3 OSTOMY CARE GLOBAL MARKET SHARE ANALYSIS
3.12.4 ADULT DIAPERS GLOBAL MARKET SHARE ANALYSIS
3.12.4.1 North America adult diapers market share analysis
3.12.4.2 Europe adult diapers market share analysis
3.12.4.3 Asia-Pacific adult diapers market share analysis
3.12.4.4 Rest of the world adult diapers market share analysis
3.13 INCONTINENCE AND OSTOMY CARE COMPANY COMPARISON TABLE BY PRODUCT TYPE, PRODUCT NAME AND APPLICATION
4 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 INCONTINENCE CARE
4.2.1 INCONTINENCE CARE GLOBAL MARKET BY DISEASE TYPE
4.2.1.1 Urinary incontinence
4.2.1.2 Fecal incontinence
4.2.2 INCONTINENCE CARE GLOBAL MARKET BY PRODUCT TYPE
4.2.2.1 Disposables
4.2.2.1.1 Adult diaper
4.2.2.1.1.1 Underwear & briefs
4.2.2.1.1.2 Pads & guards
4.2.2.1.1.3 Liners & drip collection (shields)
4.2.2.1.1.4 Other adult diapers
4.2.2.1.2 Incontinence catheter
4.2.2.1.3 Incontinence bags
4.2.2.1.4 Anal irrigation system
4.2.2.1.5 Pessaries
4.2.2.1.6 Other disposables
4.2.2.2 Implant devices
4.2.2.2.1 Sacral nerve stimulation (SNS)
4.2.2.2.2 Tibial nerve stimulation (TNS)
4.2.2.2.3 Artificial sphincters
4.2.2.2.4 Slings
4.3 OSTOMY CARE
4.3.1 OSTOMY CARE GLOBAL MARKET BY SURGERY TYPE
4.3.1.1 Colostomy
4.3.1.2 Ileostomy
4.3.1.3 Urostomy
4.3.2 OSTOMY CARE GLOBAL MARKET BY PRODUCT TYPE
4.3.2.1 Ostomy bags
4.3.2.1.1 One-piece ostomy bags
4.3.2.1.2 Two-piece ostomy bags
4.3.2.2 Skin barrier
4.3.2.3 Deodorant
4.3.2.4 Irrigation products
4.3.2.5 Other ostomy care
5 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY UTILITY
5.1 INTRODUCTION
5.2 SECURITY AND LEAKAGE CONTROL
5.3 ODOR CONTROL
5.4 PROTECTION AND CLEANSING
5.5 IRRIGATION PRODUCTS
6 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 WOMEN HEALTH RELATED
6.3 GI TRACT DISEASES
6.4 ONCOLOGY
6.5 NEUROLOGICAL CONDITIONS
6.6 URINOGENITAL DISEASES
6.7 OTHER DISEASES
7 INCONTINENCE AND OSTOMY CARE GLOBAL MARKET, BY END-USER
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 HOMECARE
7.4 OTHER END-USER
8 REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 REST OF NORTH AMERICA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 U.K.
8.3.4 REST OF EUROPE
8.4 APAC
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 REST OF APAC
8.5 ROW
8.5.1 BRAZIL
8.5.2 REST OF LATAM
8.5.3 MIDDLE EAST & AFRICA
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 ACQUISITION AND PARTNERSHIP
9.3 PRODUCT LAUNCH
9.4 PRODUCT APPROVAL
9.5 OTHERS
10 MAJOR COMPANIES
10.1 COLOPLAST A/S
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 CONVATEC GROUP PLC
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 DOMTAR CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 ESSITY AKTIEBOLAG (PUBL)
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 HOLLISTER INCORPORATED
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 KIMBERLY-CLARK CORPORATION
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 MEDTRONIC, PLC.
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 ONTEX
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 PAUL HARTMANN AG
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 UNICHARM CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
*If Applicable.